Morgan Stanley Maintains Underweight on Bright Health Gr, Raises Price Target to $12800
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser maintains an Underweight rating on Bright Health Gr (NYSE:BHG) and raises the price target from $160 to $12,800.
May 22, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley maintains an Underweight rating on Bright Health Gr (NYSE:BHG) and raises the price target from $160 to $12,800.
The news directly mentions Bright Health Gr (BHG) and the price target increase by Morgan Stanley. However, the Underweight rating remains unchanged, indicating that the analyst still expects the stock to underperform. The short-term impact on the stock price is likely to be neutral as the price target increase may be offset by the maintained Underweight rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100